D-0543-2026 Class II Ongoing

Recalled by ANI Pharmaceuticals, Inc. — Baudette, MN

FDA drug recall D-0543-2026 was initiated by ANI Pharmaceuticals, Inc. on May 12, 2026 and is designated Class II. Reason for recall: Defective Container; packets were found to be either empty or partially full. The recall status is ongoing. Affected quantity: 3964 Cartons.

Recall details

Product Type
Drugs
Report Date
May 27, 2026
Initiation Date
May 12, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3964 Cartons

Product description

Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20

Reason for recall

Defective Container; packets were found to be either empty or partially full.

Distribution pattern

Nationwide in the USA

Code information

Lot M251109, exp Nov 2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0543-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0543-2026. Report a data issue: hello@regdatalab.com.